Početna › Lupusni nefritis › Ohio
Kliničke studije za Lupusni nefritis u državi Ohio
7 studija za Lupusni nefritis traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
Službeni tekst studije (engleski)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Cleveland Clinic Foundation, Cleveland
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05268289The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- i još 1
U tijeku regrutacijaFaza 2
Od 8 do 20 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT05538208A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Cincinnati Childrens Hospital, Cincinnati
U tijeku regrutacijaFaza 2
Od 5 do 17 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT05039619Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
- GSK Investigational Site, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 2. srp 2026. · NCT06527872A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- The MetroHealth System, Cleveland
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 15. tra 2026. · NCT05934149Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
- Nephrology Clinical Trials Unit The Ohio State University Wexner Medical Center, Columbus
U tijeku regrutacijaFaza 4
Od 18 do 80 godina · Oba spola · Ažurirano 6. stu 2025. · NCT07225387Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.